Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

February 29, 2016

Conditions

Friedreich's Ataxia

Interventions

DRUG

Placebo

Placebo capsules

DRUG

EPI-743 400 mg

DRUG

EPI-743 200 mg

Trial Locations (3)

Childrens Hospital of Philadelphia, Philadelphia

University of South Florida, Tampa

University of California Los Angeles, Los Angeles